Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Asset ManagementConsolidated Net IncomeEBITEBITDAEBTEPS (Weighted Average and Diluted)Financial Services FeesIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - Fed FundsInterest Income - NetInterest Income - TotalInterest Income - Trading Account AssetsInvestment Gain (Loss)Net Income - MinorityNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeNon-Interest IncomeOperating ExpensesOther Operating ExpensesProfit After TaxProvisionsRent ExpenseResearch & DevelopmentRevenueService ChargesShares Outstanding (Diluted Average)Tax ProvisionsTax RateTax RateTrading IncomeWages, Salaries and Other
Others
Ratios

Nomura Holdings (NMR) Research & Development (2016 - 2026)

Nomura Holdings has reported Research & Development over the past 18 years, most recently at $60.1 million for Q1 2026.

  • For Q1 2026, Research & Development rose 19.12% year-over-year to $60.1 million; the TTM value through Mar 2026 reached $222.7 million, up 25.44%, while the annual FY2026 figure was $214.8 million, 21.1% up from the prior year.
  • Research & Development for Q1 2026 was $60.1 million at Nomura Holdings, down from $64.9 million in the prior quarter.
  • Over five years, Research & Development peaked at $64.9 million in Q4 2025 and troughed at $34.8 million in Q1 2022.
  • A 5-year average of $45.3 million and a median of $44.7 million in 2022 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: fell 6.96% in 2024 and later surged 45.02% in 2025.
  • Year by year, Research & Development stood at $44.7 million in 2022, then fell by 6.76% to $41.7 million in 2023, then increased by 7.49% to $44.8 million in 2024, then surged by 45.02% to $64.9 million in 2025, then fell by 7.47% to $60.1 million in 2026.
  • Business Quant data shows Research & Development for NMR at $60.1 million in Q1 2026, $64.9 million in Q4 2025, and $49.4 million in Q3 2025.